PMID: 25784483Mar 19, 2015Paper

Potential crosstalk between cofilin-1 and EGFR pathways in cisplatin resistance of non-small-cell lung cancer

Oncotarget
Carolina Beatriz MüllerFabio Klamt

Abstract

Current challenge in oncology is to establish the concept of personalized medicine in clinical practice. In this context, non-small-cell lung cancer (NSCLC) presents clinical, histological and molecular heterogeneity, being one of the most genomically diverse of all cancers. Recent advances added Epidermal Growth Factor Receptor (EGFR) as a predictive biomarker for patients with advanced NSCLC. In tumors with activating EGFR mutations, tyrosine kinase inhibitors (TKI) are indicated as first-line treatment, although restricted to a very small target population. In this context, cofilin-1 (a cytosolic protein involved with actin dynamics) has been widely studied as a biomarker of an aggressive phenotype in tumors, and overexpression of cofilin-1 is associated with cisplatin resistance and poor prognosis in NSCLC. Here, we gather information about the predictive potential of cofilin-1 and reviewed the crosstalk between cofilin-1/EGFR pathways. We aimed to highlight new perspectives of how these interactions might affect cisplatin resistance in NSCLC. We propose that cofilin-1 quantification in clinical samples in combination with presence/absence of EGFR mutation could be used to select patients that would benefit from TKI's treat...Continue Reading

References

Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·E NishidaH Sakai
May 1, 1993·Experimental Cell Research·H AbeT Obinata
Oct 18, 1996·The Journal of Biological Chemistry·G NeblY Samstag
Jul 3, 1997·Nature·P Lappalainen, D G Drubin
Apr 27, 2001·Seminars in Cancer Biology·J S CondeelisJ E Segall
Dec 17, 2002·Oncogene·Moran BenharAlexander Levitzki
Jun 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kiyoko YoshiokaKazuyuki Itoh
Mar 25, 2005·Nature Reviews. Drug Discovery·Dong Wang, Stephen J Lippard
Nov 7, 2006·Cancer Treatment Reviews·Cara A Rabik, M Eileen Dolan
Nov 7, 2006·Biochimica Et Biophysica Acta·Paul DowlingMartin Clynes
Feb 7, 2007·The Journal of Biological Chemistry·Sheng-Chieh Hsu, Mien-Chie Hung
May 25, 2007·Nature Reviews. Cancer·Weigang WangJohn Condeelis
Nov 21, 2007·The Journal of Cell Biology·Mazen SidaniJohn Condeelis
Dec 19, 2007·The Journal of Cell Biology·Jacco van RheenenJohn S Condeelis
Nov 14, 2008·Acta histochemica·Benedict YanMarian Priyanthi Kumarasinghe
Jan 19, 2010·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Klaus DittmannH Peter Rodemann
Jan 22, 2010·Current Alzheimer Research·J R BamburgO Wiggan
Aug 3, 2010·Biochemical and Biophysical Research Communications·Ying-Nai WangMien-Chie Hung
Jan 5, 2011·Frontiers in Bioscience (Elite Edition)·Carolina Beatriz MullerFabio Klamt
May 3, 2011·Current Genomics·Luca EspositoAntonio Giordano
Jun 21, 2011·Molecular Cancer·Brice V McConnellArthur Gutierrez-Hartmann
Jun 28, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Klaus DittmannH Peter Rodemann
Jul 8, 2011·Journal of Cancer Research and Clinical Oncology·Carolina B MüllerFábio Klamt
Aug 9, 2011·Biochemical and Biophysical Research Communications·Eun-Kyung LeeChan-Wha Kim
Aug 9, 2011·Molecular and Cellular Biochemistry·Rui WeiQing Zhou
Nov 8, 2011·Clinics in Chest Medicine·Jill E Larsen, John D Minna
Nov 23, 2011·The Journal of Cell Biology·Marco A O MagalhaesJohn Condeelis
Feb 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Joseph DopieMaria K Vartiainen
Sep 25, 2012·Metabolism: Clinical and Experimental·Madhu Kalia

❮ Previous
Next ❯

Citations

Sep 8, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Yan ZhangHongming Chen
Apr 2, 2019·Cancer Biomarkers : Section a of Disease Markers·Yujing QinZhijia Zhan
Nov 23, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Qing-Feng TangPei-Hao Yin
Nov 24, 2016·International Journal of Oncology·Zhiwei XuYan Tan
Jun 27, 2018·Journal of Experimental & Clinical Cancer Research : CR·Linlin ZhuBin Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.